drugset / Trial / NCT04144855
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection
NaSingle-groupOpen-labelTreatment
Summary
This is a study to evaluate the tolerance, dose-limiting toxicity (DLT), phase II recommended dose (RP2D), and maximum tolerated dose (MTD) of single and multiple oral doses of TQB3474 in patients with advanced malignant tumors.
Timeline
- Start
- 2018-11-27
- Primary completion
- 2020-11-27
- Completion
- 2021-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQB3474 | Unknown | — | Intravenous |
Indications
No indication recorded.